Argonne, Chicago Form Technology Transfer Unit

CHICAGO—A joint venture between the University of Chicago and Argonne National Laboratory marks another step forward in the burgeoning campaign to hasten the transfer of technology from the laboratory to the marketplace. The new corporation will be responsible for developing business applications for discoveries made not only at Argonne, which is operated by the university for the Department of Energy, but also within the various university laboratories. The new joint venture makes use of


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CHICAGO—A joint venture between the University of Chicago and Argonne National Laboratory marks another step forward in the burgeoning campaign to hasten the transfer of technology from the laboratory to the marketplace. The new corporation will be responsible for developing business applications for discoveries made not only at Argonne, which is operated by the university for the Department of Energy, but also within the various university laboratories. The new joint venture makes use of a 1984 federal law that gives contractors the patent rights in advance for work done in the laboratory and paid for by the government. The dozen laboratories operated for the Department of Energy by private contractors are expected to follow differing strategies for commercializing discoveries. Martin Marietta Energy Systems, which operates Oak Ridge National Laboratory, has expanded its own technology transfer division to nurture good ideas, while Battelle Development Corporation, which for the past 20 years ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio